Lindsey Weed, Ph.D., currently serves as a Senior Scientific Business Analyst at TetraScience, a position held since April 2025, following a role as Scientific Business Analyst IV. Prior experience includes serving as a Ph.D. candidate at the University of Pennsylvania School of Medicine from August 2014 to June 2019, where research focused on AAV-mediated gene therapy challenges in the retina. Lindsey also worked as a Postdoctoral Research Fellow at The Janssen Pharmaceutical Companies of Johnson & Johnson from June 2019 to April 2021, specializing in AAV-mediated gene therapy and production optimization. A subsequent position as Senior Scientist at Rejuvenate Bio from April 2021 to January 2022 involved leading projects related to AAV administration effects in canines. Academic qualifications include a Bachelor of Science in Genetics from Clemson University and a Doctor of Philosophy in Cellular and Molecular Biology from the University of Pennsylvania School of Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices